There was no significant difference in mean circuit life between heparin given via circuit (n = 169 circuits; mean circuit life 19.8 hours) and epoprostenol alone (n = 119 circuits; mean circuit life 20.9 hours). In a small group of patients on heparin via the circuit, epoprostenol was ...
The suggested beneficial effects of heparin in the studies by Kuwaki et al. and the absence of an effect for LMWH in this study may be attributed to a variety of differences including the form of heparin used, the timing of the initial dose and differences in the immunosuppressive regimens ...
Warfarin or Low-Molecular-Weight Heparin Therapy does not Prolong Pig-To-Primate Cardiac Xenograft Function Microvascular thrombosis is a prominent feature in cardiac delayed xenograft rejection (DXR). We investigated the impact of warfarin or low-molecular-weigh... GW Byrne,JM Schirmer,DN Fass,.....
(VEGF–189 and VEGF–206) bind heparin with high affinity and are sequestered in the extracellular matrix. The smaller isoform, VEGF– 121, does not bind heparin and is freely diffusible. VEGF–165 has both bioavailability and biologic potency. VEGF–165 is the predominant isoform and the ...
Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. Am J Transplant 2005; 5: 1011-1020.Byrne GW, Schirmer JM, Fass DN, et al. Warfarin or low- molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function ...
Warfarin or low-molecular-weight heparin therapy does not pro- long pig-to-primate cardiac xenograft function. Am J Transplant. 2005;5:1011-20.BYRNE GW, SCHIRMER JM, FASS DN et al. Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function. ...